We deliver powerful, reliable tools that fuel scientific discoveries and drive exponential progress to master biology to advance human health. Cited in more than 8,200 research papers, our innovative single cell, spatial, and in situ technologies enable discoveries across oncology, immunology, neuroscience, and more. Our talented, dedicated science professionals have a distinguished record of creating innovative instruments, reagents, and software that analyze biological systems at a resolution that matches the complexity of biology.

We are a BBSRC-funded network to support and enhance engagement between the Bioscience and AI communities in the UK. The network will support community events, funding of pilot projects and creation of resources for supporting use of AI in the biosciences.

We are, first and foremost, a community network. We have a Management Group to guide and help shape the network; an external Steering Group with representatives from academia, industry, and funding bodies which meets once per year and provides oversight; and a set of three Working Groups with specific focusses.

Alafia Ai, Inc. Provides a high-performance precision medicine platform for bioinformaticians, pathologists, and clinicians; designed to accelerate scientific and medical discoveries in hospitals, cancer and imaging centers, research institutions, pharmaceutical organizations and biotechnology companies. Our vision is to create a healthcare ecosystem that is interconnected, intelligent, and infinitely adaptable, ensuring that every patient receives the highest standard of care.

AstraZeneca is a global, science-led and patient-focused company. It’s committed to transforming healthcare and is contributing sustainably to people, society and the planet.

We’re transforming people’s health, from preventing and treating, to one day curing diseases.

We’re helping create healthier societies, collaborating with our partners to tackle major health challenges.

We recognise the strong connection between a healthy planet and healthy people and are taking bold action on climate change.

AstraZeneca.
What science can do.

BioFAIR is a UKRI funded federated digital research infrastructure (£34million over 5 years).

BioFAIR will deliver a step change in ‘Findable, Accessible, Interoperable and Re-usable’ (FAIR) research data management, providing end-to-end FAIR research data management & analysis capabilities along with the necessary support and training for UK researchers working in the life sciences.

Working with national Digital Research Infrastructures and related national and international data hubs, BioFAIR aims to improve productivity for researchers, raise the quality of data sets and analysis pipelines, and stimulate the uptake of standards and best practices in research data management.

Bioinformatics Advances is a fully open access, peer-reviewed journal published jointly by Oxford University Press and by the International Society for Computational Biology. The journal publishes original research articles, reviews, application notes, opinion, perspective and Society features.

Since 1999, Bioinformatics.ca has served as a hub for bioinformatics and computational biology for Canadian researchers. Through the Canadian Bioinformatics Workshops, Bioinformatics.ca provides short-form training to Canadian and international researchers on a range of current bioinformatics topics from single-cell RNA sequencing and proteomics to pharmacogenomic analysis. Bioinformatics.ca also supports local communities through its Bioinformatics User Groups (BUGs) and promotes Canadian bioinformatics experts and post-secondary programs.

At Brandeis Online you can earn a world-class education at a top, R1 institution with a commitment to path-breaking research and scholarship from wherever you reside. All online degrees and certificates are taught by faculty who are experts in their fields. Faculty create inclusive and engaging learning environments for students. Our featured programs are a Master of Science in Bioinformatics and Master’s Certificates in Cheminformatics, Drug Discovery Informatics and Genomics.

BSC is at the service of the international scientific community and of industry that requires HPC resources. Our multidisciplinary research team and our computational facilities –including MareNostrum– make BSC an international centre of excellence in e-Science.

Since its establishment in 2005, BSC has developed an active role in promoting HPC in Spain and Europe as an essential tool for international competitiveness in science and engineering. The centre manages the Red Española de Supercomputación (RES), and was a founding and hosting member of the former European HPC infrastructure PRACE (Partnership for Advanced Computing in Europe), and is now hosting entity for EuroHPC JU, the Joint Undertaking that leads large-scale investments and HPC provision in Europe. We actively participate in the main European HPC initiatives, in close cooperation with other European supercomputing centres.

BSC has been successful in attracting talent, and our research focuses on five fields: Computer Sciences, Life Sciences, Earth Sciences, Computer Applications in Science and Engineering and Computational Social Sciences and Humanities. Our research lines are developed within the framework of European Union research funding programmes, Spanish and Catalan public research calls and collaborations with leading companies.

The Black Women in Computational Biology Network is a global online networking platform with the mission of accelerating opportunity at the intersection of biology, math, and computer science. We do this through community-centered initiatives that center our 300+ members as scientists, build connections with our 3,000+ supporters and the broader STEM community, and create transformative growth opportunities that enrich the social capital of Black women in the field.

The University of Cambridge sits at the heart of one of the world’s largest technology clusters. The Cambridge cluster is home to over 5,000 knowledge-intensive companies. It is the birthplace of 24 businesses valued at more than $1 billion (£800 million).

Cambridge promotes the interface between academia and business, and has a global reputation for innovation.

Collaborative Drug Discovery (CDD) provides an intuitive software suite extensively used by creative biologists and chemists working in academic, biotechnology and pharmaceutical settings. Their flagship product, CDD Vault, enables researchers to intuitively organize and analyze both biological and chemical data, and to collaborate with partners through a straightforward web interface.

Challenge Works unearths innovations to solve problems that matter. We focus on improving health, climate adaptation and mitigation, and social inclusion. We believe in big ideas. Bold thinking. Creative problem-solving. We believe that great things happen when people come together. That, given the right support, unexpected ideas truly can change the world.

Corteva Agriscience is a global pure-play agriculture company that provides farmers around the world with the most complete portfolio in the industry - including a balanced and diverse mix of seed, crop protection and digital solutions focused on maximizing productivity to enhance yield and profitability. With some of the most recognized brands in agriculture and an industry-leading product and technology pipeline well positioned to drive growth, the company is committed to working with stakeholders throughout the food system as it fulfills its promise to enrich the lives of those who produce and those who consume, ensuring progress for generations to come. More information can be found at www.corteva.com

Is it possible to cure, prevent and manage all disease by the end of this century? We think so. In the last 100 years, biomedical science has made tremendous strides in understanding biological systems and treating disease, but much more can be achieved in the years to come. We are at a pivotal moment in science where the intersection of artificial intelligence and biology has the potential to transform how biological research is done and solve some of the most complex challenges in human health. At CZI, we are pursuing four scientific grand challenges to produce breakthroughs and accelerate science to significantly decrease the burden of human disease.

The Digital Research Alliance of Canada (the Alliance) fosters pan-Canadian and global collaboration to provide researcher-centric, sustainable and integrated digital research infrastructure. By championing and funding the infrastructure and activities required for advanced research computing, research data management and research software, the Alliance transforms how research across all academic disciplines is organized, managed, stored and used.

EMBL’s European Bioinformatics Institute (EMBL-EBI) is a global leader in the storage, analysis and dissemination of large, open biological data.

We help scientists realise the potential of big data by enhancing their ability to exploit complex information to make discoveries that benefit humankind.

We are at the forefront of computational biology research, with work spanning AI methods, sequence analysis, multi-dimensional statistical analysis and data-driven biological discovery, from molecules to ecosystems.

We are part of EMBL and are located on the Wellcome Genome Campus (UK), one of the world’s largest concentrations of scientific and technical expertise in genomics.

The European Conference on Computational Biology (ECCB) is the leading European gathering for scientists working in computational biology, bioinformatics, and data-driven life sciences. Held every two years in a different European city - and jointly organized with ISMB (International Conference on Intelligent Systems for Molecular Biology) in odd-numbered years - ECCB provides a unique space for researchers to share ideas, explore new methods, and drive innovation in the field.

From 31 August to 4 September 2026, Geneva will become a hub for computational biology, welcoming scientists and researchers from across Europe for a week of discovery, collaboration, and exchange. Organized by the SIB Swiss Institute of Bioinformatics, this edition is expected to welcome over a thousand experts to explore the latest advancements in genomics, transcriptomics, structural bioinformatics, systems biology, medicine and environmental bioinformatics.

With a strong focus on discoveries and their applications, ECCB unites bioinformaticians, computational biologists, developers, biocurators, and clinicians to tackle key biological challenges. Whether to present research, exchange ideas, or build new collaborations, ECCB 2026 offers a dynamic and inspiring environment to connect with the global computational biology community.

eLife is an independent nonprofit committed to improving the way research is reviewed and communicated in the life sciences and medicine. Earlier this year we introduced a new model of publishing that puts preprints first and emphasises public reviews and assessments of research. This system makes sharing of research faster and fairer, while still providing robust peer review and quality assessment.

ELIXIR is an intergovernmental organisation that brings together life science resources, including databases, software tools, training materials, and cloud storage from across Europe. ELIXIR’s services are run by ELIXIR Nodes, interconnected centres of excellence throughout Europe, coordinated by the ELIXIR Hub in the UK. Currently, there are 22 members and two observers, bringing together over 220 research organisations.

The UK Node of ELIXIR represents UK strengths in bioinformatics within ELIXIR and provides a route for UK bioinformatics resources to participate in ELIXIR. The UK node is made up of a number of organisations throughout the UK with the coordination office being located at Earlham Institute.

F1000Research is an Open Research publishing platform for scientists, scholars and clinicians across all disciplines offering rapid publication of articles and other research outputs without editorial bias. We publish research across all academic disciplines and in multiple formats, including original articles, data notes, software tool articles and method articles.

Frontiers in Bioinformatics is a young open-access journal, led by Prof. Adam Godzik (University of California Riverside). The journal provides a forum where new discoveries in all aspects of bioinformatics and the analysis of biological data are presented. Frontiers in Bioinformatics focuses on new bioinformatics tools and novel applications that can bring new insights to specific biological problems, efforts that cross standard field boundaries.

At Fulgent Genetics our comprehensive test options are designed to provide actionable genetic and diagnostic insights. Through our diverse testing menu, Fulgent is focused on transforming patient care in oncology, anatomic pathology, infectious and rare diseases, and reproductive health. We believe that by providing a wide range of effective, flexible testing options in conjunction with best-in-class service and support, we can redefine the way medicine is managed for patients and clinicians alike.

The School of Future Technology was established in 2021 and is one of the first 12 Schools of Future Technology nationwide approved by the MoE. With a strategic focus on faculty development, academic innovation, and cutting-edge research, The School has been granted doctoral degree-awarding authority in Artificial Intelligence.

GOBLET is an international organisation with the mission to cultivate a global community of bioinformatics trainers who support learning, education and training. GOBLET’s mission was defined under the vision that there is a clear need to harmonise bioinformatics training activities and to unite, inspire, and equip bioinformatics trainers worldwide. Towards this, GOBLET collaborates with national and international bioinformatics organisations. Relevant activities include the initiation of a series of standards and guidelines, work on the definition of competencies, promotion of best practices, and providing high-quality resources for learning, education and training in bioinformatics and computational biology, on a global scale.

As one of ISCB’s Journals of Interest, Genomics, Proteomics & Bioinformatics (GPB) welcomes quality submissions on omics and bioinformatics worldwide, ranked Q1 in WoS category Genetics & Heredity with real-time IF of 8.9. GPB is the official journal of Beijing Institute of Genomics, CAS / /China National Center for Bioinformation, and Genetics Society of China. It is published by Elsevier and will be published by Oxford University Press from 2024. Follow GPB at Twitter (GPBees).

GlaxoSmithKline (GSK) is a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We focus on four therapeutic areas: infectious diseases, HIV, immunology/respiratory and oncology. At the heart of this is our R&D focus on the science of the immune system, human genetics, genomics and advanced technologies, and our world-leading capabilities in vaccines and medicines development. Computational Biology and more generally Data Science play a key role in supporting our R&D strategy and pipeline.

The Harvard Medical School Department of Biomedical Informatics offers a variety of opportunities to increase your knowledge base and skill set in the application of quantitative principles to biomedical discovery. Come learn about our educational programs which include a Master’s, PhD, and Summer Institute and hear about our postdoctoral fellowships, faculty positions and other career opportunities.

Visit our booth to learn more about educational and career opportunities. For more information please visit: http://dbmi.hms.harvard.edu

We are an independent, registered charity supported by 10 funders, working across 31 locations within the UK, with our Central Team based in London.

Our mission is to unite the UK’s health and care data to enable discoveries that improve people’s lives. We do this by uniting, improving and using health and care data as one national institute.

The Human Frontier Science Program (HFSP) is unique, supporting international collaboration to undertake innovative, risky, basic research at the frontier of the life sciences. Special emphasis is given to the support and training of independent young investigators, beginning at the postdoctoral level. The Program is supported financially by Australia, Canada, France, Germany, India, Israel, Italy, Japan, the Republic of Korea, New Zealand, Norway, Singapore, South Africa, Switzerland, the United Kingdom, the United States of America, and the European Commission. Since 1990, over 7500 researchers from more than 70 countries have been supported. Of these, 28 HFSP awardees have gone on to receive the Nobel Prize.

With 3,000+ researchers in 12 labs on six continents focused on Accelerated Discovery and Exploratory Sciences, IBM Research pioneers the most promising and disruptive technologies in hybrid cloud, AI and quantum computing. The combination of increasingly powerful computers and AI offers the possibility to be able to detect, diagnose, understand and cure diseases like never before. At IBM Research, we’re working on creating software and AI systems that can convert reams of health data into useable information for researchers and clinicians the world over. Scientific discovery is driven by two forces: the development of new capabilities and the relentless tenacity of the world’s sharpest minds. We see it as our duty to accelerate scientific progress by developing cutting-edge technologies, demonstrating scalable processes, and deploying new models of collaborative innovation.

At Illumina, our mission is to improve human health by unlocking the power of the genome. Our sequencing by synthesis chemistry is used to generate high-accuracy DNA and RNA sequence data in studies around the globe. Integrating seamlessly with our sequencing systems, Illumina Connected Software supports genomic and clinical customers from primary through tertiary analysis and optimizes lab and sample management. The innovative products that we provide are facilitating breakthroughs in many scientific areas, including oncology, reproductive health, genetic disease, precision medicine, agriculture, microbiology, and beyond. The progress we see being made in genomics inspires us to push the boundaries of what is possible so we can create the next generation of genomics solutions.

The International Society for Computational Biology (ISCB) (www.iscb.org) was the first and continues to be the only society representing computational biology and bioinformatics worldwide. ISCB serves a global community of nearly 3,400 scientists dedicated to advancing the scientific understanding of living systems through computation by:

• convening the world’s experts and future leaders in top conferences
• partnering with publications that promote discovery and expand access to computational biology and bioinformatics
• delivering valuable information about training, education, employment, and relevant news
• providing an influential voice on government and scientific policies that are important to our members

ISCB has three official journals – OUP Bioinformatics, PLOS Computational Biology and F1000Research ISCB Community Journal, and has affiliations in place with several other publications for the benefit of our members.

Computational biology and bioinformatics are disciplines that explore the laws of life sciences with the calculation of biological data as the core means, and are the cutting-edge disciplines with a high degree of intersection of information, mathematics, intelligent science and life sciences. With the successful implementation of the Human Genome Project and the rapid development of a series of high-throughput biotechnology, information technology and artificial intelligence technologies in the new century, the role of computational biology and bioinformatics in life science and medical research has become increasingly prominent, becoming the only way to solve the complex mechanism of life systems. ISCB is the earliest and most influential international academic organization established in this cutting-edge cross-cutting field, and plays an increasingly important role in leading bioinformatics scientific research, talent training and applications in medicine, medicine, agriculture, industry, environment and other fields.

In order to further promote the development of bioinformatics and computational biology in China, strengthen the links between Chinese scholars and their international counterparts, and promote international exchanges and cooperation, under the promotion and leadership of Zhang Xueong, a professor at Tsinghua University and the first Asian vice president of ISCB, on May 6, 2024, Tsinghua University and the International Society of Computational Biology (ISCB) officially signed a long-term cooperation agreement on the establishment of the ISCB China Secretariat (ISCB) at Tsinghua University (Department of Automation), responsible for carrying out various tasks in China on behalf of ISCB.

ISCB Student Council (SC, www.iscbsc.org) is an international network of young researchers in the broader disciplines of the field of Computational Biology. SC provides opportunities for networking, career enhancement and skills development for the next generation of Computational Biology leaders. The SC Symposium (symposium.iscbsc.org) is organized as a part of the annual ISMB conference with student presentations, keynotes, panel discussions and a poster session. Come visit our friendly SC representatives at the booth for more information.

The IUCr is an International Scientific Union. Its objectives are to promote international cooperation in crystallography and to contribute to all aspects of crystallography, to promote international publication of crystallographic research, to facilitate standardization of methods, units, nomenclatures and symbols, and to form a focus for the relations of crystallography to other sciences.

The Jackson Laboratory (JAX) is an independent, nonprofit biomedical research organization that leverages a unique combination of research, education and resources to achieve our mission:
We DISCOVER precise genomic solutions for disease and EMPOWER the global biomedical community in its shared quest to improve human health.

The Liverpool City Region Combined Authority is led by Mayor Steve Rotheram and brings together region’s six local councils – Halton, Knowsley, Liverpool, Sefton, St Helens and Wirral – to tackle the big issues that matter to us all, together.

The authority has taken powers and funding from the national government to through a ‘devolution’ deal. This means that we can take decisions and make investments locally, where we know what our region needs, instead of them being taken by politicians and officials in London.

Through the Combined Authority, we work together to make investments in areas that have a real impact on our communities, like transport, employment and skills, culture, digital and housing. By using the devolved powers we have, we can make a real and meaningful difference to the lives of the people living and working in the area.

UAE’s visionary leaders established MBZUAI to educate and develop top talent, foster an innovation ecosystem, and act as a strategic think tank for the public and private sectors.

MBZUAI takes inspiration from our namesake, His Highness Sheikh Mohamed bin Zayed Al Nahyan, President of the UAE.

The University has a vital role to play in many of the UAE Government’s strategic objectives, with AI identified as a critical component for future growth and prosperity. MBZUAI’s own strategic vision and mission works in parallel to position Abu Dhabi as a hub for the international AI community.

The University attracts world-class thinkers and doers in computer vision, machine learning, natural language processing, and beyond.

Our groundbreaking academic and research initiatives are working on developing future solutions that will impact the world and change the way we imagine things.

Life is an international, peer-reviewed, open access journal of scientific studies related to fundamental themes in life sciences, published monthly online by MDPI. It publishes topics include, but are not limited to biomolecular design, activation and function; molecular evolution; biomolecular trafficking, and networks; membranes, and molecular organization in cells. We encourage the submission of manuscripts that fall in the broad areas of:
Structural biology
Computational biology
Biochemistry and biophysics of subcellular and molecular processes

As the world's enterprises accelerate their digital transformations, they discover that next-generation applications must deal with data that are bigger and faster at the same time, outstripping the capabilities of today's infrastructure. MemVerge's mission is to deliver a new architecture, called Big Memory Computing, that converges memory and storage, thereby removing the storage I/O bottleneck once and for all. MemVerge's Memory Machine™ Software virtualizes heterogeneous memory hardware into a software-defined memory service that has both high capacity and high performance. MemVerge ZeroIO™ In-Memory Snapshot technology captures the state of running applications, and can be used for application roll-back, cloning and high availability. The results are new levels of productivity, performance, availability, and mobility for today's data-centric applications, both on-premises and in the cloud.

1. How and when system engineering techniques find their application in highly developed biological models
2. System level analogies between complex control and automation devices and biological entities
3. Negative feedback control loops and signalling in biochemical pathways
4. System analysis, signal integrity and fault detection in biochemical pathway
5. Localization and bypass of a defect on the metabolic pathways using control & system engineering techniques

MGI Tech Co., Ltd. (or its subsidiaries, together referred to MGI), is committed to building core tools and technologies that drive innovation in life science. Our focus lies in research & development, manufacturing, and sales of instruments, reagents, and related products in the field of life science and biotechnology. We provide real-time, multi-omics, and full spectrum of digital equipment and systems for precision medicine, agriculture, healthcare and various other industries.

Oxford University Press publishes a range of computational biology journals, including Bioinformatics, Bioinformatics Advances, GigaScience, Nucleic Acids Research, NAR Genomics and Bioinformatics, Database, Briefings in Bioinformatics, Briefings in Functional Genomics, and more. Bioinformatics publishes the highest quality scientific papers and review articles with its main focus is on new developments in genome bioinformatics and computational biology.

Overleaf is a free, collaborative, cloud-based LaTeX editor which makes the process of writing, editing and publishing scientific documents quicker and easier. This intuitive online platform has seen rapid adoption across science and research, and Overleaf's award-winning collaboration technology is now in use by over 9 million researchers, students and technical writers in institutions, labs and industry worldwide. It’s simple and intuitive to use – all you need is a web browser – try it out and use it for free at www.overleaf.com.

PerMedCoE is Europe's HPC/Exascale Centre of Excellence for Personalised Medicine that leverages clinical and omics data to revolutionise disease treatment at an individual level. By optimising core applications and integrating them with new HPC/Exascale platforms, the project allows for the simulation of cell-level models for personalised treatments. Through comprehensive use cases, training, and collaboration with the biomedical consortia, this EU-funded Center of Excellence bridges the gap between molecular and organ-level simulations

At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time.

The Royal Society journals Journal of the Royal Society Interface and Interface Focus regularly publish high-quality cross-disciplinary research at the boundary between the physical and life sciences, including computational and systems biology. We welcome research, reviews, and proposals for themed issues from scientists working in these areas. Both sides of the boundary are considered equally, and Journal of the Royal Society Interface and Interface Focus are some of the only journals to cover this exciting new territory.

Seqera makes complex data analysis accessible at any scale. Our software helps scientists solve today's most complex problems and drives innovation in genomics, global health, and beyond. Integrating fragmented data and diverse computing resources into a unified platform, Seqera’s modern biotech stack is trusted by more than 150 leading life science organizations including AstraZeneca, Roche, and Johnson & Johnson. Scientists empowered with modern software engineering conduct science faster, on larger datasets, and with more confidence. Seqera accelerates discoveries in an open world.

The SFBI is the French Bioinformatics Society. Its mission is to promote interdisciplinary research in France at the interface between Molecular Biology, Computer Science, Mathematics and Statistics, Physics. By collaborating with the other French bioinformatics actors (GDR-BIM and IFB), SFBI brings together the whole French community. SFBI organizes every year the French Bioinformatics conference called JOBIM. By setting up networks, SFBI also supports training, the professional insertion of young bioinformaticians, research projects and educational innovation.

The SIB Swiss Institute of Bioinformatics is an internationally recognized non-profit organization, dedicated to biological and biomedical data science. Its data scientists are passionate about creating knowledge and solving complex questions in many fields, from biodiversity and evolution to medicine, by providing essential databases and software platforms as well as bioinformatics expertise and services to academic, clinical, and industry groups.

St. Jude Children’s Research Hospital is a top-ranked Pediatric Cancer Hospital and a world-renowned basic and translational science and clinical research institute with over 200 faculty members. St. Jude offers a highly collaborative research and training environment that includes state-of-the-art facilities and resources. Postdoctoral research fellows will receive a competitive salary, excellent benefits, and a professional development allowance. To find out more about our research facilities and benefits for postdocs, click here.

Syngenta plays a vital role in enabling the food chain to feed the world safely and take care of our planet. Our ambition is to be the most collaborative and trusted team in agriculture, providing leading seeds and crop protection innovations to enhance the prosperity of farmers, wherever they are.

We are a technology company that has built the world’s largest library of clinical and molecular data and an operating system to make that data accessible and useful, starting with cancer. Our goal is for each patient to benefit from the treatment of others who came before.

We’re looking for people who can help us change the world. Who question the status quo and don’t shy away from tough problems. For the builders who are never done building and the learners who are never done learning. We’re looking for passionate people with undying curiosity. Those who want to attack one of the most challenging problems ever faced… head on.

Founded in 1975, the USC Leonard Davis School of Gerontology is the oldest and largest school of its type in the world. We offer the most comprehensive selection of gerontology degree programs found anywhere, a variety of outstanding research opportunities and a challenging yet supportive academic environment. As a small school rooted in a world-class research university located in the heart of one of the most important cities on earth, the USC Leonard Davis School of Gerontology—and its research and services arm, the Ethel Percy Andrus Gerontology Center—are home to today’s leaders in the field, and to tomorrow’s. Our program studies the human lifespan by exploring the biological, psychological, sociological, political, medical and business dimensions of adult life. The curriculum is aimed at equipping future professionals in the field of aging with the specific skills and knowledge necessary to respond effectively to the needs of an aging population.

Founded in 1975, the USC Leonard Davis School of Gerontology is the oldest and largest school of its type in the world. We offer the most comprehensive selection of gerontology degree programs found anywhere, a variety of outstanding research opportunities and a challenging yet supportive academic environment. As a small school rooted in a world-class research university located in the heart of one of the most important cities on earth, the USC Leonard Davis School of Gerontology—and its research and services arm, the Ethel Percy Andrus Gerontology Center—are home to today’s leaders in the field, and to tomorrow’s. Our program studies the human lifespan by exploring the biological, psychological, sociological, political, medical and business dimensions of adult life. The curriculum is aimed at equipping future professionals in the field of aging with the specific skills and knowledge necessary to respond effectively to the needs of an aging population.

Biomedical Data Science (BDS) encompasses the study and pursuit of the effective uses of biomedical data, information, and knowledge for scientific inquiry, problem-solving, and decision-making, driven by efforts to improve human health. The graduate programs in BDS blend the best of statistics, computer sciences, biostatistics and biomedical informatics and train students to develop computational and mathematical approaches to analyze large-scale biomedical data and to lead collaborative, interdisciplinary team science efforts.

VIZomics develops a sustainable open-source ecosystem (OSE) for collaborative research and education in mechanistic biology. It is funded through an NSF grant (#2346274) to transform iCn3D into an OSE, empowering a global community to advance 3D web-based biomolecular visualization, structural analysis, research collaborations and education. iCn3D (https://github.com/ncbi/icn3d) was originally developed at the NIH with the capability to visualize, analyze and share 3D visualizations (molecular scenes) and analyses through a FAIR mechanism, ensuring reproducibility. VIZomics democratizes access to 3D molecular graphics for researchers, educators, and students and aims to foster collaboration among them worldwide via a global developer community. We support education through interactive tools and training, and immersive VR represents a major advance for classrooms. At ISMB 2025, we will present an iCn3D-based immersive VR platform that should be invaluable for education and for collaborative research. At VIZomics we believe that the convergence between the Web, AI and VR can realize its full potential in Biology through the community. Join us: visit www.VIZomics.org or contact us at This email address is being protected from spambots. You need JavaScript enabled to view it. .

X-omics is a National Roadmap Large-Scale Research Infrastructure, partially funded by NWO with a budget of 40 million euro. X-omics aims to establish a multi-omics research infrastructure across the Netherlands, by combining technologies in the field of genomics, proteomics, metabolomics and data analysis, integration & stewardship. With this infrastructure biomedical problems can be solved using an integrated approach. Two major goals are:

1. Advance X-omics technologies far beyond state-of-art,
2. Realize an integrated X-omics infrastructure.

Zhejiang Lab (hereinafter referred to as ZJ Lab), a non-profit research institution, was established on September 6, 2017 based on the collective efforts of Zhejiang Province, China. With its research focus on intelligent computing, ZJ Lab aims at the three major strategic needs for national strategic frontiers, scientific research paradigm revolution, and innovation of strategic industry advancement. It serves as an innovation source that supports the innovative development in Zhejiang, and strives to become a world-leading scientific and technological innovation base.